Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in moderate to severe COPD
NCT00056264Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2002
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in chronic obstructive pulmonary disease (COPD), sponsored by Janssen Pharmaceutical. Started Dec 2002; status: completed.
02
Drugs
infliximab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00056264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056264.